Insmed Incorporated (INSM)
USD 65.88
(-4.77%)
USD 65.88
(-4.77%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 239.63 Million USD | 25.97% |
| 2022 | 190.23 Million USD | 31.82% |
| 2021 | 144.3 Million USD | 15.87% |
| 2020 | 124.54 Million USD | 10.94% |
| 2019 | 112.25 Million USD | 1414.5% |
| 2018 | 7.41 Million USD | 355.5% |
| 2017 | -2.9 Million USD | -18.99% |
| 2016 | -2.43 Million USD | -23.01% |
| 2015 | -1.98 Million USD | 91.01% |
| 2014 | -22.03 Million USD | -21.45% |
| 2013 | -18.14 Million USD | 15.09% |
| 2012 | -21.36 Million USD | -583.79% |
| 2011 | 4.41 Million USD | -36.18% |
| 2010 | 6.92 Million USD | -33.28% |
| 2009 | 10.37 Million USD | -11.33% |
| 2008 | 11.69 Million USD | 68.26% |
| 2007 | 6.95 Million USD | 1493.39% |
| 2006 | -499 Thousand USD | -480.92% |
| 2005 | 131 Thousand USD | -4.38% |
| 2004 | 137 Thousand USD | -8.67% |
| 2003 | 150 Thousand USD | -92.33% |
| 2002 | 1.95 Million USD | 560.47% |
| 2001 | 296 Thousand USD | 393.33% |
| 2000 | 60 Thousand USD | -92.0% |
| 1999 | 749.73 Thousand USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 68.11 Million USD | 19.96% |
| 2024 Q3 | 72.25 Million USD | 6.08% |
| 2024 Q1 | 56.78 Million USD | -12.98% |
| 2023 Q4 | 65.25 Million USD | 4.62% |
| 2023 Q1 | 51.38 Million USD | 11.15% |
| 2023 Q2 | 60.63 Million USD | 18.0% |
| 2023 Q3 | 62.36 Million USD | 2.85% |
| 2023 FY | 239.63 Million USD | 25.97% |
| 2022 Q2 | 48.82 Million USD | 19.33% |
| 2022 Q4 | 46.23 Million USD | -14.8% |
| 2022 Q3 | 54.25 Million USD | 11.13% |
| 2022 FY | 190.23 Million USD | 31.82% |
| 2022 Q1 | 40.91 Million USD | -4.48% |
| 2021 Q4 | 42.83 Million USD | 17.12% |
| 2021 Q2 | 34.52 Million USD | 13.69% |
| 2021 Q1 | 30.37 Million USD | -0.6% |
| 2021 FY | 144.3 Million USD | 15.87% |
| 2021 Q3 | 36.57 Million USD | 5.92% |
| 2020 Q4 | 30.55 Million USD | -7.47% |
| 2020 Q1 | 28.42 Million USD | -23.19% |
| 2020 FY | 124.54 Million USD | 10.94% |
| 2020 Q2 | 32.54 Million USD | 14.51% |
| 2020 Q3 | 33.02 Million USD | 1.46% |
| 2019 FY | 112.25 Million USD | 1414.5% |
| 2019 Q3 | 32.44 Million USD | 29.52% |
| 2019 Q4 | 37 Million USD | 14.03% |
| 2019 Q1 | 17.75 Million USD | 139.5% |
| 2019 Q2 | 25.05 Million USD | 41.13% |
| 2018 Q1 | -17.38 Million USD | 19.7% |
| 2018 Q4 | 7.41 Million USD | 130.7% |
| 2018 FY | 7.41 Million USD | 355.5% |
| 2018 Q2 | -21.39 Million USD | -23.09% |
| 2018 Q3 | -24.14 Million USD | -12.86% |
| 2017 FY | -2.9 Million USD | -18.99% |
| 2017 Q4 | -21.64 Million USD | -30.71% |
| 2017 Q1 | -12.58 Million USD | 73.44% |
| 2017 Q2 | -17.23 Million USD | -36.89% |
| 2017 Q3 | -16.56 Million USD | 3.89% |
| 2016 FY | -2.43 Million USD | -23.01% |
| 2016 Q4 | -47.39 Million USD | -264.67% |
| 2016 Q3 | -12.99 Million USD | 13.22% |
| 2016 Q2 | -14.97 Million USD | -25.8% |
| 2016 Q1 | -11.9 Million USD | 9.63% |
| 2015 Q3 | -13.18 Million USD | -6.44% |
| 2015 Q2 | -12.38 Million USD | -14.03% |
| 2015 Q1 | -10.86 Million USD | -504.09% |
| 2015 FY | -1.98 Million USD | 91.01% |
| 2015 Q4 | -13.17 Million USD | 0.08% |
| 2014 FY | -22.03 Million USD | -21.45% |
| 2014 Q3 | -9.17 Million USD | -0.77% |
| 2014 Q2 | -9.1 Million USD | 0.0% |
| 2014 Q1 | - USD | 100.0% |
| 2014 Q4 | 2.68 Million USD | 129.29% |
| 2013 Q2 | 3.12 Million USD | 0.0% |
| 2013 Q4 | -41.14 Million USD | 0.0% |
| 2013 FY | -18.14 Million USD | 15.09% |
| 2013 Q1 | - USD | 100.0% |
| 2013 Q3 | - USD | -100.0% |
| 2012 Q2 | - USD | 0.0% |
| 2012 Q3 | - USD | 0.0% |
| 2012 Q4 | -8.5 Million USD | 0.0% |
| 2012 FY | -21.36 Million USD | -583.79% |
| 2012 Q1 | - USD | -100.0% |
| 2011 Q1 | 1.6 Million USD | 21.2% |
| 2011 FY | 4.41 Million USD | -36.18% |
| 2011 Q2 | 978 Thousand USD | -38.91% |
| 2011 Q3 | 435 Thousand USD | -55.52% |
| 2011 Q4 | 1.4 Million USD | 222.53% |
| 2010 Q1 | 1.92 Million USD | -22.47% |
| 2010 Q2 | 1.86 Million USD | -3.37% |
| 2010 Q3 | 1.8 Million USD | -3.06% |
| 2010 Q4 | 1.32 Million USD | -26.9% |
| 2010 FY | 6.92 Million USD | -33.28% |
| 2009 Q1 | 2.37 Million USD | -17.1% |
| 2009 Q3 | 2.47 Million USD | -18.59% |
| 2009 Q4 | 2.48 Million USD | 0.53% |
| 2009 FY | 10.37 Million USD | -11.33% |
| 2009 Q2 | 3.04 Million USD | 28.27% |
| 2008 Q2 | 2.64 Million USD | 14.29% |
| 2008 Q4 | 2.85 Million USD | -29.77% |
| 2008 Q1 | 2.31 Million USD | -60.52% |
| 2008 FY | 11.69 Million USD | 68.26% |
| 2008 Q3 | 4.07 Million USD | 53.74% |
| 2007 Q4 | 5.86 Million USD | 304.2% |
| 2007 Q3 | 1.45 Million USD | -36.18% |
| 2007 Q2 | 2.27 Million USD | 109.87% |
| 2007 Q1 | 1.08 Million USD | 424.55% |
| 2007 FY | 6.95 Million USD | 1493.39% |
| 2006 Q3 | -405 Thousand USD | -316.58% |
| 2006 Q2 | 187 Thousand USD | 246.3% |
| 2006 Q4 | -334 Thousand USD | 17.53% |
| 2006 Q1 | 54 Thousand USD | 125.0% |
| 2006 FY | -499 Thousand USD | -480.92% |
| 2005 Q1 | 57 Thousand USD | 147.83% |
| 2005 FY | 131 Thousand USD | -4.38% |
| 2005 Q2 | 28 Thousand USD | -50.88% |
| 2005 Q3 | 22 Thousand USD | -21.43% |
| 2005 Q4 | 24 Thousand USD | 9.09% |
| 2004 Q2 | 29 Thousand USD | -52.46% |
| 2004 Q1 | 61 Thousand USD | 125.93% |
| 2004 FY | 137 Thousand USD | -8.67% |
| 2004 Q4 | 23 Thousand USD | -4.17% |
| 2004 Q3 | 24 Thousand USD | -17.24% |
| 2003 Q2 | 34 Thousand USD | -45.16% |
| 2003 FY | 150 Thousand USD | -92.33% |
| 2003 Q1 | 62 Thousand USD | 138.46% |
| 2003 Q4 | 27 Thousand USD | 0.0% |
| 2003 Q3 | 27 Thousand USD | -20.59% |
| 2002 Q3 | 1.75 Million USD | 2410.0% |
| 2002 Q4 | 26 Thousand USD | -98.52% |
| 2002 Q2 | 70 Thousand USD | -31.37% |
| 2002 Q1 | 102 Thousand USD | 67.21% |
| 2002 FY | 1.95 Million USD | 560.47% |
| 2001 Q4 | 61 Thousand USD | -7.58% |
| 2001 FY | 296 Thousand USD | 393.33% |
| 2001 Q2 | 69 Thousand USD | -31.0% |
| 2001 Q1 | 100 Thousand USD | 220.48% |
| 2001 Q3 | 66 Thousand USD | -4.35% |
| 2000 Q1 | 112 Thousand USD | 0.0% |
| 2000 FY | 60 Thousand USD | -92.0% |
| 2000 Q2 | 94 Thousand USD | -16.07% |
| 2000 Q4 | -83 Thousand USD | -122.31% |
| 2000 Q3 | 372 Thousand USD | 295.74% |
| 1999 Q2 | 236 Thousand USD | 40.48% |
| 1999 Q1 | 168 Thousand USD | 0.0% |
| 1999 FY | 749.73 Thousand USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| AbCellera Biologics Inc. | 38.02 Million USD | -530.204% |
| Alkermes plc | 1.37 Billion USD | 82.568% |
| Agenus Inc. | 139.61 Million USD | -71.64% |
| Aptorum Group Limited | -1.11 Million USD | 21597.944% |
| Ardelyx, Inc. | 106.66 Million USD | -124.67% |
| Dyadic International, Inc. | 922.95 Thousand USD | -25863.831% |
| Eton Pharmaceuticals, Inc. | 21.06 Million USD | -1037.814% |
| Lantern Pharma Inc. | -174.84 Thousand USD | 137157.246% |
| Inhibikase Therapeutics, Inc. | -13.35 Million USD | 1893.964% |
| Novavax, Inc. | 639.93 Million USD | 62.553% |
| Janux Therapeutics, Inc. | -46.83 Million USD | 611.614% |
| Pyxis Oncology, Inc. | -2 Million USD | 12081.75% |
| TransCode Therapeutics, Inc. | -516.74 Thousand USD | 46473.847% |
| Ocuphire Pharma, Inc. | 19.04 Million USD | -1158.389% |
| Outlook Therapeutics, Inc. | -44.18 Thousand USD | 542407.866% |
| Madrigal Pharmaceuticals, Inc. | -527 Thousand USD | 45571.537% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| SELLAS Life Sciences Group, Inc. | - USD | -Infinity% |
| Syros Pharmaceuticals, Inc. | -98.21 Million USD | 343.985% |
| Barinthus Biotherapeutics plc | 802 Thousand USD | -29779.676% |
| Windtree Therapeutics, Inc. | -82 Thousand USD | 292337.805% |
| Xeris Biopharma Holdings, Inc. | 135.26 Million USD | -77.154% |
| Clearside Biomedical, Inc. | 7.87 Million USD | -2944.531% |
| C4 Therapeutics, Inc. | -96.95 Million USD | 347.174% |
| Alnylam Pharmaceuticals, Inc. | 1.51 Billion USD | 84.213% |
| AlloVir, Inc. | -398 Thousand USD | 60309.799% |
| Arrowhead Pharmaceuticals, Inc. | 240.73 Million USD | 0.457% |
| VYNE Therapeutics Inc. | 424 Thousand USD | -56417.689% |
| Bicycle Therapeutics plc | -129.52 Million USD | 285.018% |
| BioXcel Therapeutics, Inc. | 120 Thousand USD | -199595.833% |
| ChromaDex Corporation | 50.78 Million USD | -371.908% |
| Chimerix, Inc. | 324 Thousand USD | -73861.42% |
| Corbus Pharmaceuticals Holdings, Inc. | -31.16 Million USD | 868.858% |
| Caribou Biosciences, Inc. | -77.59 Million USD | 408.816% |
| CRISPR Therapeutics AG | 240.95 Million USD | 0.548% |
| Precision BioSciences, Inc. | 40.47 Million USD | -492.101% |
| Fate Therapeutics, Inc. | -98.16 Million USD | 344.119% |
| Fortress Biotech, Inc. | 57.85 Million USD | -314.214% |
| Fortress Biotech, Inc. | 57.85 Million USD | -314.214% |
| HOOKIPA Pharma Inc. | 16.57 Million USD | -1345.587% |
| ImmuCell Corporation | 4.39 Million USD | -5350.853% |
| IDEAYA Biosciences, Inc. | -106.12 Million USD | 325.809% |
| Immix Biopharma, Inc. | -5468.00 USD | 4382598.171% |
| Incyte Corporation | 3.44 Billion USD | 93.035% |
| Innoviva, Inc. | 261.06 Million USD | 8.209% |
| IO Biotech, Inc. | -756 Thousand USD | 31797.751% |
| Jaguar Health, Inc. | 7.72 Million USD | -3002.473% |
| Keros Therapeutics, Inc. | -664 Thousand USD | 36189.608% |
| Ligand Pharmaceuticals Incorporated | 119.75 Million USD | -100.108% |
| ContextLogic Inc. | 59 Million USD | -306.161% |
| MiMedx Group, Inc. | 266.84 Million USD | 10.196% |
| MEI Pharma, Inc. | 49.32 Million USD | -385.809% |
| NextCure, Inc. | -3.68 Million USD | 6604.75% |
| Onconetix, Inc. | -1.12 Million USD | 21359.975% |
| Oncternal Therapeutics, Inc. | -28.96 Million USD | 927.24% |
| Opthea Limited | 21.72 Thousand USD | -1103191.897% |
| Psyence Biomedical Ltd. | -240.00 USD | 99848016.667% |
| Vaxcyte, Inc. | -75 Million USD | 419.513% |
| PDS Biotechnology Corporation | -57.32 Thousand USD | 418121.491% |
| Precigen, Inc. | 106 Thousand USD | -225970.755% |
| Pharming Group N.V. | 220.1 Million USD | -8.874% |
| Phathom Pharmaceuticals, Inc. | 515 Thousand USD | -46431.068% |
| Pieris Pharmaceuticals, Inc. | 1 Million USD | -23649.752% |
| PureTech Health plc | -1.6 Million USD | 15049.158% |
| Rigel Pharmaceuticals, Inc. | 109.77 Million USD | -118.302% |
| Avidity Biosciences, Inc. | -181.4 Million USD | 232.097% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Sangamo Therapeutics, Inc. | -45.32 Million USD | 628.704% |
| Sol-Gel Technologies Ltd. | -21.98 Million USD | 1189.894% |
| Acelyrin, Inc. | -115 Thousand USD | 208478.261% |
| Salarius Pharmaceuticals, Inc. | -10.05 Thousand USD | 2384290.628% |
| Summit Therapeutics Inc. | -2.05 Million USD | 11789.512% |
| Sensei Biotherapeutics, Inc. | -571 Thousand USD | 42067.601% |
| Senti Biosciences, Inc. | -2.68 Million USD | 9031.606% |
| Stoke Therapeutics, Inc. | 4.05 Million USD | -5815.453% |
| Elevation Oncology, Inc. | -39 Thousand USD | 614548.718% |
| Alaunos Therapeutics, Inc. | -4.79 Million USD | 5094.477% |
| Telomir Pharmaceuticals, Inc. Common Stock | -3.94 Million USD | 6178.947% |
| Entrada Therapeutics, Inc. | 29.12 Million USD | -722.668% |
| VistaGen Therapeutics, Inc. | 496 Thousand USD | -48213.508% |
| Kintara Therapeutics, Inc. | -55 Thousand USD | 435800.0% |
| Wave Life Sciences Ltd. | 104.09 Million USD | -130.199% |
| Seer, Inc. | 7.02 Million USD | -3310.204% |
| Verrica Pharmaceuticals Inc. | 4.37 Million USD | -5373.618% |
| Aadi Bioscience, Inc. | 21.54 Million USD | -1012.253% |
| ESSA Pharma Inc. | -118.49 Thousand USD | 202338.989% |
| GlycoMimetics, Inc. | -143.3 Thousand USD | 167324.932% |
| GT Biopharma, Inc. | - USD | -Infinity% |
| Inhibrx Biosciences, Inc. | 609 Thousand USD | -39248.933% |
| Akebia Therapeutics, Inc. | 120.47 Million USD | -98.91% |
| Catalyst Pharmaceuticals, Inc. | 313.67 Million USD | 23.603% |
| Longboard Pharmaceuticals, Inc. | -5000.00 USD | 4792800.0% |
| Orchestra BioMed Holdings, Inc. | 2.57 Million USD | -9209.829% |
| Alzamend Neuro, Inc. | -50.74 Thousand USD | 472380.252% |
| Sorrento Therapeutics, Inc. | 29.38 Million USD | -715.446% |
| TRACON Pharmaceuticals, Inc. | -232 Thousand USD | 103390.948% |
| Viracta Therapeutics, Inc. | -492 Thousand USD | 48806.301% |
| Rocket Pharmaceuticals, Inc. | -7.09 Million USD | 3476.092% |
| Aptose Biosciences Inc. | -474.54 Thousand USD | 50597.845% |
| ZyVersa Therapeutics, Inc. | -10.4 Thousand USD | 2304282.692% |
| Soligenix, Inc. | 97.31 Thousand USD | -246156.847% |
| Century Therapeutics, Inc. | -10.8 Million USD | 2316.995% |
| Kura Oncology, Inc. | -849 Thousand USD | 28325.559% |
| TScan Therapeutics, Inc. | -67.1 Million USD | 457.11% |
| Intensity Therapeutics, Inc. | -147 Thousand USD | 163117.007% |
| Ocean Biomedical, Inc. | - USD | -Infinity% |
| CytomX Therapeutics, Inc. | 99.03 Million USD | -141.96% |
| Autolus Therapeutics plc | -4.86 Million USD | 5023.67% |
| Mineralys Therapeutics, Inc. | - USD | -Infinity% |
| EyePoint Pharmaceuticals, Inc. | 41.38 Million USD | -479.024% |
| Eterna Therapeutics Inc. | -168 Thousand USD | 142739.881% |
| Adaptive Biotechnologies Corporation | 94.72 Million USD | -152.985% |
| GRI Bio, Inc. | 10.84 Million USD | -2110.451% |
| Xenetic Biosciences, Inc. | 2.53 Million USD | -9334.501% |
| Tenaya Therapeutics, Inc. | -8.68 Million USD | 2858.547% |
| IGM Biosciences, Inc. | -211.66 Million USD | 213.217% |
| INmune Bio, Inc. | 155 Thousand USD | -154503.226% |
| Heron Therapeutics, Inc. | 61.93 Million USD | -286.889% |
| SAB Biotherapeutics, Inc. | -1.5 Million USD | 16008.945% |
| Pasithea Therapeutics Corp. | -648.45 Thousand USD | 37054.819% |
| Entero Therapeutics, Inc. | -29.27 Thousand USD | 818693.291% |
| Milestone Pharmaceuticals Inc. | 402 Thousand USD | -59510.697% |
| X4 Pharmaceuticals, Inc. | -1.99 Million USD | 12105.762% |
| Atara Biotherapeutics, Inc. | -313 Thousand USD | 76660.703% |
| Coherus BioSciences, Inc. | 94.46 Million USD | -153.687% |
| Verastem, Inc. | -62 Thousand USD | 386608.065% |
| Abeona Therapeutics Inc. | 2.43 Million USD | -9741.273% |
| Pliant Therapeutics, Inc. | -261 Thousand USD | 91914.176% |
| Tonix Pharmaceuticals Holding Corp. | 3.02 Million USD | -7816.584% |
| Histogen Inc. | 3.76 Million USD | -6258.053% |
| Aprea Therapeutics, Inc. | 576.17 Thousand USD | -41490.374% |
| Surrozen, Inc. | -27.23 Million USD | 980.04% |
| Organovo Holdings, Inc. | -5.38 Million USD | 4546.743% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Ovid Therapeutics Inc. | -1.2 Million USD | 19988.703% |
| Panbela Therapeutics, Inc. | -25.64 Million USD | 1034.359% |
| CASI Pharmaceuticals, Inc. | 20.05 Million USD | -1095.068% |
| Cadrenal Therapeutics, Inc. Common Stock | -1980.00 USD | 12102877.778% |
| Centessa Pharmaceuticals plc | 6.06 Million USD | -3850.186% |
| Hepion Pharmaceuticals, Inc. | -67.13 Thousand USD | 357066.23% |
| Arcturus Therapeutics Holdings Inc. | 154.79 Million USD | -54.812% |
| BioRestorative Therapies, Inc. | 145.8 Thousand USD | -164258.711% |
| Apollomics, Inc. | 127 Thousand USD | -188588.976% |
| Amarin Corporation plc | 165.54 Million USD | -44.759% |
| Mesoblast Limited | -9.81 Million USD | 2541.518% |
| Turnstone Biologics Corp. | 16.5 Million USD | -1351.805% |
| Kymera Therapeutics, Inc. | -110.48 Million USD | 316.886% |
| Synaptogenix, Inc. | -6347.00 USD | 3775663.258% |
| Tiziana Life Sciences Ltd | -51 Thousand USD | 469972.549% |
| Aurinia Pharmaceuticals Inc. | 161.36 Million USD | -48.505% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Monopar Therapeutics Inc. | - USD | -Infinity% |
| Exelixis, Inc. | 1.75 Billion USD | 86.366% |
| Better Therapeutics, Inc. | -2.72 Million USD | 8881.055% |
| Nurix Therapeutics, Inc. | -112.16 Million USD | 313.653% |
| Apellis Pharmaceuticals, Inc. | 338.08 Million USD | 29.119% |
| NLS Pharmaceutics AG | -11.4 Thousand USD | 2100687.307% |
| Dermata Therapeutics, Inc. | - USD | -Infinity% |
| Aridis Pharmaceuticals, Inc. | - USD | -Infinity% |
| Gritstone bio, Inc. | -6.26 Million USD | 3928.035% |
| Jasper Therapeutics, Inc. | -1.1 Million USD | 21727.708% |
| TNF Pharmaceuticals, Inc. | - USD | -Infinity% |
| Avid Bioservices, Inc. | 7.31 Million USD | -3174.596% |
| Virpax Pharmaceuticals, Inc. | - USD | -Infinity% |
| MediWound Ltd. | 3.57 Million USD | -6597.457% |
| OmniAb, Inc. | 14.66 Million USD | -1533.838% |
| Alector, Inc. | -95.05 Million USD | 352.107% |
| Seres Therapeutics, Inc. | 125.62 Million USD | -90.76% |
| Checkpoint Therapeutics, Inc. | -43.46 Million USD | 651.354% |
| Zai Lab Limited | 170.9 Million USD | -40.217% |
| Revance Therapeutics, Inc. | 81.87 Million USD | -192.677% |
| Aura Biosciences, Inc. | -1.29 Million USD | 18604.633% |
| Lyell Immunopharma, Inc. | 130 Thousand USD | -184234.615% |
| Immunic, Inc. | -111 Thousand USD | 215987.387% |
| Tarsus Pharmaceuticals, Inc. | 15.85 Million USD | -1411.511% |
| Veracyte, Inc. | 248.14 Million USD | 3.431% |
| InMed Pharmaceuticals Inc. | -6.98 Billion USD | 103.429% |
| FibroGen, Inc. | 128.9 Million USD | -85.902% |
| SeaStar Medical Holding Corporation | - USD | -Infinity% |
| Adial Pharmaceuticals, Inc. | -564.00 USD | 42488575.177% |
| Sonnet BioTherapeutics Holdings, Inc. | -11.66 Million USD | 2153.976% |
| Jazz Pharmaceuticals plc | 3.39 Billion USD | 92.949% |
| Cyclacel Pharmaceuticals, Inc. | 389 Thousand USD | -61502.828% |
| Amylyx Pharmaceuticals, Inc. | 355.34 Million USD | 32.563% |
| TG Therapeutics, Inc. | 219.1 Million USD | -9.368% |
| Galecto, Inc. | -830 Thousand USD | 28971.687% |
| Calithera Biosciences, Inc. | -1.38 Million USD | 17402.166% |
| Fortrea Holdings Inc. | 424 Million USD | 43.482% |
| KalVista Pharmaceuticals, Inc. | -86.16 Million USD | 378.105% |
| Aptevo Therapeutics Inc. | -567 Thousand USD | 42363.668% |
| XBiotech Inc. | -1.74 Million USD | 13840.539% |
| Jasper Therapeutics, Inc. | -1.1 Million USD | 21727.708% |
| Lyra Therapeutics, Inc. | -46.47 Million USD | 615.666% |
| Foghorn Therapeutics Inc. | -75.53 Million USD | 417.254% |
| Y-mAbs Therapeutics, Inc. | 73.4 Million USD | -226.465% |
| Theravance Biopharma, Inc. | 16.8 Million USD | -1326.144% |
| Ultragenyx Pharmaceutical Inc. | 389.04 Million USD | 38.404% |
| Metagenomi, Inc. Common Stock | -49.64 Million USD | 582.678% |
| Vaxxinity, Inc. | -2.23 Million USD | 10826.723% |
| BioCryst Pharmaceuticals, Inc. | 326.75 Million USD | 26.661% |
| Gain Therapeutics, Inc. | -11.32 Million USD | 2216.199% |
| Cartesian Therapeutics, Inc. | 24.45 Million USD | -880.062% |
| NexImmune, Inc. | -1.02 Million USD | 23479.663% |
| Creative Medical Technology Holdings, Inc. | 5400.00 USD | -4437585.185% |
| Marker Therapeutics, Inc. | -7.1 Million USD | 3472.454% |
| Regeneron Pharmaceuticals, Inc. | 11.3 Billion USD | 97.88% |
| Chemomab Therapeutics Ltd. | -66.82 Thousand USD | 358690.091% |
| Scopus BioPharma Inc. | - USD | -Infinity% |
| RAPT Therapeutics, Inc. | -3.55 Million USD | 6848.381% |
| Ainos, Inc. | -253.73 Thousand USD | 94543.766% |
| Pluri Inc. | 322 Thousand USD | -74320.807% |
| Prothena Corporation plc | -129.2 Million USD | 285.475% |
| Adaptimmune Therapeutics plc | 50.42 Million USD | -375.241% |
| Celularity Inc. | 6.75 Million USD | -3447.52% |
| Rallybio Corporation | -150 Thousand USD | 159856.667% |
| Cue Biopharma, Inc. | -32.6 Million USD | 834.919% |
| MeiraGTx Holdings plc | 287 Thousand USD | -83396.516% |
| Omeros Corporation | -69.77 Million USD | 443.42% |
| Humacyte, Inc. | -76.55 Million USD | 413.044% |
| Immunocore Holdings plc | 248.39 Million USD | 3.525% |
| Cocrystal Pharma, Inc. | -15.16 Million USD | 1679.768% |
| Cidara Therapeutics, Inc. | 62.38 Million USD | -284.141% |
| Blueprint Medicines Corporation | 236.58 Million USD | -1.29% |
| CalciMedica, Inc. | -58 Thousand USD | 413263.793% |
| Cabaletta Bio, Inc. | -1.42 Million USD | 16904.698% |
| Marinus Pharmaceuticals, Inc. | 29.05 Million USD | -724.763% |
| Scholar Rock Holding Corporation | -2.84 Million USD | 8525.985% |
| Sana Biotechnology, Inc. | -30.86 Million USD | 876.397% |
| Pulmatrix, Inc. | -8.22 Million USD | 3015.268% |
| Elicio Therapeutics, Inc. | -1.17 Million USD | 20581.624% |
| Vigil Neuroscience, Inc. | -399 Thousand USD | 60158.897% |
| Intellia Therapeutics, Inc. | -398.79 Million USD | 160.09% |
| Adlai Nortye Ltd. American Depositary Shares | 2.77 Million USD | -8533.675% |
| Cytokinetics, Incorporated | -322.59 Million USD | 174.284% |
| Eloxx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Nutriband Inc. | 862.1 Thousand USD | -27696.498% |
| Protara Therapeutics, Inc. | -341 Thousand USD | 70374.194% |
| Vor Biopharma Inc. | -3.49 Million USD | 6962.4% |
| Roivant Sciences Ltd. | 109.23 Million USD | -119.376% |
| Evogene Ltd. | 1.39 Million USD | -17029.021% |
| ProKidney Corp. | -3.16 Million USD | 7661.849% |
| Applied Therapeutics, Inc. | -43.91 Million USD | 645.716% |
| Hoth Therapeutics, Inc. | - USD | -Infinity% |
| BridgeBio Pharma, Inc. | 6.85 Million USD | -3394.75% |
| CorMedix Inc. | -205.56 Thousand USD | 116675.534% |
| BioLineRx Ltd. | 1.1 Million USD | -21527.708% |
| Tango Therapeutics, Inc. | -78.67 Million USD | 404.604% |
| Galectin Therapeutics Inc. | -33 Thousand USD | 726266.667% |
| Atai Life Sciences N.V. | -5000.00 USD | 4792800.0% |
| Renovaro Biosciences Inc. | -121.85 Thousand USD | 196749.406% |
| Aerovate Therapeutics, Inc. | -96 Thousand USD | 249719.792% |
| Zentalis Pharmaceuticals, Inc. | -1.38 Million USD | 17352.34% |
| Sagimet Biosciences Inc. | 2 Million USD | -11881.75% |
| MediciNova, Inc. | 979.7 Thousand USD | -24359.914% |
| Praxis Precision Medicines, Inc. | -84.31 Million USD | 384.2% |
| Cardio Diagnostics Holdings, Inc. | -94.55 Thousand USD | 253534.509% |
| GeoVax Labs, Inc. | -20.72 Million USD | 1256.497% |
| Axsome Therapeutics, Inc. | 244.53 Million USD | 2.004% |
| Biomea Fusion, Inc. | -4.2 Million USD | 5804.237% |
| PTC Therapeutics, Inc. | 872.33 Million USD | 72.53% |
| Mereo BioPharma Group plc | 7.42 Million USD | -3126.973% |
| Cullinan Oncology, Inc. | -310 Thousand USD | 77401.613% |
| Syndax Pharmaceuticals, Inc. | -12 Thousand USD | 1997058.333% |
| Absci Corporation | -41.84 Million USD | 672.618% |
| NRx Pharmaceuticals, Inc. | -5000.00 USD | 4792800.0% |
| 4D Molecular Therapeutics, Inc. | -76.37 Million USD | 413.769% |
| Dyne Therapeutics, Inc. | -2.46 Million USD | 9837.302% |
| Kiniksa Pharmaceuticals, Ltd. | 213.73 Million USD | -12.118% |
| Ventyx Biosciences, Inc. | -941 Thousand USD | 25565.994% |
| Allakos Inc. | -6.14 Million USD | 4002.215% |
| Imunon, Inc. | -720 Thousand USD | 33382.408% |
| Fulcrum Therapeutics, Inc. | -68.99 Million USD | 447.317% |
| Corcept Therapeutics Incorporated | 475.89 Million USD | 49.645% |
| BioAtla, Inc. | -103.73 Million USD | 331.016% |
| NLS Pharmaceutics AG | -11.4 Thousand USD | 2100687.307% |
| Bio-Path Holdings, Inc. | -178 Thousand USD | 134726.404% |
| Allogene Therapeutics, Inc. | -242.81 Million USD | 198.689% |
| Larimar Therapeutics, Inc. | -311 Thousand USD | 77153.055% |
| XOMA Corporation | 3.86 Million USD | -6106.553% |
| Kezar Life Sciences, Inc. | -70.08 Million USD | 441.921% |
| Cara Therapeutics, Inc. | 14.79 Million USD | -1519.812% |
| aTyr Pharma, Inc. | -2.38 Million USD | 10134.966% |
| Aligos Therapeutics, Inc. | 12.46 Million USD | -1823.234% |
| Akero Therapeutics, Inc. | -29 Thousand USD | 826427.586% |
| Viridian Therapeutics, Inc. | -1 Million USD | 23873.313% |
| Eliem Therapeutics, Inc. | - USD | -Infinity% |
| EyeGate Pharmaceuticals, Inc. | 13.00 USD | -1843346053.846% |
| Akari Therapeutics, Plc | -4000.00 USD | 5990975.0% |
| Tevogen Bio Holdings Inc. | - USD | -Infinity% |
| Halozyme Therapeutics, Inc. | 636.89 Million USD | 62.374% |
| Lexaria Bioscience Corp. | 194.7 Thousand USD | -122974.039% |
| UroGen Pharma Ltd. | 73.35 Million USD | -226.692% |
| Sutro Biopharma, Inc. | -26.69 Million USD | 997.711% |
| ZIVO Bioscience, Inc. | 11.61 Thousand USD | -2063939.621% |
| Orgenesis Inc. | -5.72 Million USD | 4285.764% |
| Entera Bio Ltd. | -56 Thousand USD | 428019.643% |
| GH Research PLC | -315 Thousand USD | 76174.603% |
| Lisata Therapeutics, Inc. | -189 Thousand USD | 126891.005% |
| Reneo Pharmaceuticals, Inc. | -525 Thousand USD | 45744.762% |
| Xencor, Inc. | -85.26 Million USD | 381.064% |
| 60 Degrees Pharmaceuticals, Inc. | -220.97 Thousand USD | 108543.413% |
| Replimune Group, Inc. | -2.65 Million USD | 9125.8% |
| Coeptis Therapeutics Holdings, Inc. | -1 Million USD | 24033.918% |
| Vanda Pharmaceuticals Inc. | 177.84 Million USD | -34.744% |
| Lexaria Bioscience Corp. | 194.7 Thousand USD | -122974.039% |
| Portage Biotech Inc. | -54 Thousand USD | 443868.519% |
| Cardio Diagnostics Holdings, Inc. | -94.55 Thousand USD | 253534.509% |
| Olema Pharmaceuticals, Inc. | -377 Thousand USD | 63663.66% |
| OncoCyte Corporation | 413 Thousand USD | -57923.002% |
| Qualigen Therapeutics, Inc. | -4495.00 USD | 5331245.717% |
| Processa Pharmaceuticals, Inc. | -222.00 USD | 107943793.694% |
| Purple Biotech Ltd. | -196 Thousand USD | 122362.755% |
| CollPlant Biotechnologies Ltd. | 8.96 Million USD | -2572.112% |
| scPharmaceuticals Inc. | 9.78 Million USD | -2349.755% |
| ProMIS Neurosciences, Inc. | -10.44 Million USD | 2394.265% |
| HilleVax, Inc. | -2.15 Million USD | 11214.796% |
| NeuroSense Therapeutics Ltd. | -97 Thousand USD | 247146.392% |
| Tharimmune, Inc. | - USD | -Infinity% |
| Genprex, Inc. | -15 Thousand USD | 1597240.762% |
| Neumora Therapeutics, Inc. Common Stock | -668 Thousand USD | 35973.503% |
| Atossa Therapeutics, Inc. | -23 Thousand USD | 1041991.304% |
| XTL Biopharmaceuticals Ltd. | - USD | -Infinity% |
| Virios Therapeutics, Inc. | - USD | -Infinity% |
| OKYO Pharma Limited | -7506.16 USD | 3192611.217% |
| Savara Inc. | -44.26 Million USD | 641.401% |
| Curis, Inc. | 9.81 Million USD | -2342.514% |
| Daré Bioscience, Inc. | 2.76 Million USD | -8552.576% |
| Carmell Therapeutics Corporation | -124.78 Thousand USD | 192133.689% |
| Titan Pharmaceuticals, Inc. | -1.72 Million USD | 13959.746% |
| Achieve Life Sciences, Inc. | -228 Thousand USD | 105203.07% |
| BeiGene, Ltd. | 2.07 Billion USD | 88.473% |
| Kiromic BioPharma, Inc. | -2.79 Million USD | 8670.943% |
| Revolution Medicines, Inc. Warrant | -399.66 Million USD | 159.959% |
| Protagonist Therapeutics, Inc. | 56.68 Million USD | -322.726% |
| Erasca, Inc. | -3.73 Million USD | 6521.088% |
| bluebird bio, Inc. | -4.03 Million USD | 6046.278% |
| Protagenic Therapeutics, Inc. | -28.21 Thousand USD | 849327.443% |
| BioMarin Pharmaceutical Inc. | 1.9 Billion USD | 87.417% |
| DBV Technologies S.A. | 15.72 Million USD | -1423.62% |
| Protagenic Therapeutics, Inc. | -28.21 Thousand USD | 849327.443% |
| Moderna, Inc. | 2.15 Billion USD | 88.88% |
| Vincerx Pharma, Inc. | -915 Thousand USD | 26289.617% |
| Fresh Tracks Therapeutics, Inc. | 8 Million USD | -2893.193% |
| Molecular Templates, Inc. | 50.39 Million USD | -375.513% |
| Acrivon Therapeutics, Inc. Common Stock | -536 Thousand USD | 44808.022% |
| Travere Therapeutics, Inc. | 133.78 Million USD | -79.115% |
| Monte Rosa Therapeutics, Inc. | -6.22 Million USD | 3951.414% |
| Spruce Biosciences, Inc. | -39.34 Million USD | 709.092% |
| Celldex Therapeutics, Inc. | -111.12 Million USD | 315.639% |
| Cogent Biosciences, Inc. | -3.58 Million USD | 6778.79% |
| MacroGenics, Inc. | 50.52 Million USD | -374.271% |
| RenovoRx, Inc. | - USD | -Infinity% |
| Adicet Bio, Inc. | -6.09 Million USD | 4029.731% |
| Prime Medicine, Inc. | -147.9 Million USD | 262.02% |
| Aditxt, Inc. | -111.66 Thousand USD | 214711.32% |
| Adagene Inc. | 18.11 Million USD | -1223.11% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Quantum-Si incorporated | 488 Thousand USD | -49005.533% |
| Maravai LifeSciences Holdings, Inc. | 140.2 Million USD | -70.921% |
| Acurx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Voyager Therapeutics, Inc. | 157.83 Million USD | -51.825% |
| SciSparc Ltd. | 2.19 Million USD | -10812.341% |
| Vericel Corporation | 135.57 Million USD | -76.753% |
| Revelation Biosciences, Inc. | -25.04 Thousand USD | 956764.937% |
| Minerva Neurosciences, Inc. | -30.98 Thousand USD | 773565.238% |
| Generation Bio Co. | -73.91 Million USD | 424.221% |
| Astria Therapeutics, Inc. | - USD | -Infinity% |
| Black Diamond Therapeutics, Inc. | -437 Thousand USD | 54936.384% |
| Arcutis Biotherapeutics, Inc. | 54.61 Million USD | -338.739% |
| Invivyd, Inc. | -2.02 Million USD | 11916.321% |
| Relay Therapeutics, Inc. | -300.84 Million USD | 179.655% |
| Quoin Pharmaceuticals, Ltd. | -103.43 Thousand USD | 231770.179% |
| Spero Therapeutics, Inc. | 96.36 Million USD | -148.667% |
| Artelo Biosciences, Inc. | - USD | -Infinity% |
| 2seventy bio, Inc. | 98.28 Million USD | -143.809% |
| ADMA Biologics, Inc. | 88.21 Million USD | -171.64% |
| Clene Inc. | 533 Thousand USD | -44859.662% |
| Capricor Therapeutics, Inc. | 24.1 Million USD | -893.957% |
| Boundless Bio, Inc. Common Stock | -957 Thousand USD | 25140.23% |
| GeoVax Labs, Inc. | -20.72 Million USD | 1256.497% |
| Recursion Pharmaceuticals, Inc. | 1.98 Million USD | -11954.074% |
| Citius Pharmaceuticals, Inc. | -194.31 Thousand USD | 123422.32% |
| Contineum Therapeutics, Inc. Class A Common Stock | 49.8 Million USD | -381.146% |
| Relmada Therapeutics, Inc. | - USD | -Infinity% |
| Finch Therapeutics Group, Inc. | -7.09 Million USD | 3478.948% |
| ALX Oncology Holdings Inc. | -836 Thousand USD | 28764.474% |
| Vir Biotechnology, Inc. | 83.41 Million USD | -187.28% |
| Evaxion Biotech A/S | 73.11 Thousand USD | -327664.252% |
| Ocular Therapeutix, Inc. | 53.16 Million USD | -350.764% |
| Verve Therapeutics, Inc. | -173.18 Million USD | 238.367% |
| Trevena, Inc. | 1.45 Million USD | -16369.759% |
| Surrozen, Inc. | -27.23 Million USD | 980.04% |
| Tyra Biosciences, Inc. | -353 Thousand USD | 67985.269% |
| Cingulate Inc. | -582.91 Thousand USD | 41209.556% |
| Galmed Pharmaceuticals Ltd. | -31 Thousand USD | 773116.129% |
| Unity Biotechnology, Inc. | -19.69 Million USD | 1316.483% |
| Tenax Therapeutics, Inc. | -7570.00 USD | 3165687.847% |
| Terns Pharmaceuticals, Inc. | -881 Thousand USD | 27300.341% |
| ACADIA Pharmaceuticals Inc. | 680.7 Million USD | 64.796% |
| Connect Biopharma Holdings Limited | -988 Thousand USD | 24354.555% |
| Clearmind Medicine Inc. | -56.34 Thousand USD | 425422.14% |
| Kronos Bio, Inc. | 1.37 Million USD | -17366.108% |
| Bolt Biotherapeutics, Inc. | -53.66 Million USD | 546.53% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Viking Therapeutics, Inc. | -292 Thousand USD | 82166.781% |
| Statera Biopharma, Inc. | -488.31 Thousand USD | 49173.957% |
| ImmunityBio, Inc. | -17.89 Million USD | 1439.491% |
| Korro Bio, Inc. | -3.63 Million USD | 6701.515% |
| Kineta, Inc. | 5.43 Million USD | -4310.731% |
| BioVie Inc. | -229.37 Thousand USD | 104572.114% |
| Codexis, Inc. | 57.33 Million USD | -317.963% |
| Celularity Inc. | 6.75 Million USD | -3447.52% |
| Crinetics Pharmaceuticals, Inc. | 4.01 Million USD | -5871.468% |
| Celcuity Inc. | -142.77 Thousand USD | 167944.535% |
| Virax Biolabs Group Limited | 50.59 Thousand USD | -473580.569% |
| Cibus, Inc. | 1.42 Million USD | -16751.969% |
| Eledon Pharmaceuticals, Inc. | -374 Thousand USD | 64173.529% |
| eFFECTOR Therapeutics, Inc. | -22.91 Million USD | 1145.574% |
| IN8bio, Inc. | -2.5 Million USD | 9681.567% |
| Kodiak Sciences Inc. | -25.94 Million USD | 1023.556% |
| Annexon, Inc. | -3.26 Million USD | 7435.017% |
| Adverum Biotechnologies, Inc. | -2.04 Million USD | 11823.826% |
| Assembly Biosciences, Inc. | -41.73 Million USD | 674.155% |
| Avalo Therapeutics, Inc. | 640 Thousand USD | -37342.969% |
| Ionis Pharmaceuticals, Inc. | 778.51 Million USD | 69.219% |
| Eyenovia, Inc. | - USD | -Infinity% |
| Puma Biotechnology, Inc. | 172.95 Million USD | -38.553% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| Xilio Therapeutics, Inc. | -1.9 Million USD | 12712.368% |
| Arcellx, Inc. | 108.27 Million USD | -121.313% |
| Cardiff Oncology, Inc. | -32.36 Million USD | 840.323% |
| Enanta Pharmaceuticals, Inc. | 79.2 Million USD | -202.554% |
| Regulus Therapeutics Inc. | -21.15 Million USD | 1232.919% |
| Moolec Science SA | -143.3 Thousand USD | 167320.264% |
| Acumen Pharmaceuticals, Inc. | -42.31 Million USD | 666.272% |
| Geron Corporation | -123.5 Million USD | 294.032% |
| LAVA Therapeutics N.V. | 3.28 Million USD | -7190.386% |
| Royalty Pharma plc | 1.79 Billion USD | 86.642% |
| Atea Pharmaceuticals, Inc. | -70.09 Million USD | 441.896% |
| Greenwich LifeSciences, Inc. | -3612.00 USD | 6634513.068% |
| TFF Pharmaceuticals, Inc. | 231.39 Thousand USD | -103462.801% |
| Mersana Therapeutics, Inc. | -111.41 Million USD | 315.085% |
| Humacyte, Inc. | -76.55 Million USD | 413.044% |
| Structure Therapeutics Inc. | -949.17 Thousand USD | 25346.688% |
| 89bio, Inc. | -273 Thousand USD | 87878.388% |
| PMV Pharmaceuticals, Inc. | -1.25 Million USD | 19164.041% |
| Avenue Therapeutics, Inc. | - USD | -Infinity% |
| Genelux Corporation | -848 Thousand USD | 28358.844% |
| Trevi Therapeutics, Inc. | -123 Thousand USD | 194925.203% |
| Lexicon Pharmaceuticals, Inc. | 1.11 Million USD | -21315.103% |
| Notable Labs, Ltd. | 113 Thousand USD | -211966.372% |
| Liquidia Corporation | 14.6 Million USD | -1541.336% |
| Mustang Bio, Inc. | -2.22 Million USD | 10870.112% |
| Immunovant, Inc. | -231 Thousand USD | 103838.095% |
| Quantum-Si incorporated | 488 Thousand USD | -49005.533% |
| Arbutus Biopharma Corporation | -55.55 Million USD | 531.316% |
| DiaMedica Therapeutics Inc. | -30 Thousand USD | 798883.333% |
| Vera Therapeutics, Inc. | 1.86 Million USD | -12769.764% |
| Acasti Pharma Inc. | -11 Thousand USD | 2178600.0% |
| MiNK Therapeutics, Inc. | -204.61 Thousand USD | 117213.925% |
| Pasithea Therapeutics Corp. | -648.45 Thousand USD | 37054.819% |
| Xenon Pharmaceuticals Inc. | -167.51 Million USD | 243.055% |
| Elevai Labs, Inc. Common Stock | 1.13 Million USD | -21021.032% |
| NeuroBo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Tempest Therapeutics, Inc. | -381 Thousand USD | 62996.325% |
| Soleno Therapeutics, Inc. | -1.95 Million USD | 12338.764% |
| PepGen Inc. | -1.18 Million USD | 20339.443% |
| Moleculin Biotech, Inc. | -127 Thousand USD | 188788.976% |
| United Therapeutics Corporation | 2.07 Billion USD | 88.423% |
| Nuvectis Pharma, Inc. | -22.89 Million USD | 1146.578% |
| Solid Biosciences Inc. | -76.56 Million USD | 412.991% |
| BriaCell Therapeutics Corp. | -82.58 Thousand USD | 290274.733% |
| Immuneering Corporation | -764.13 Thousand USD | 31460.173% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Silo Pharma, Inc. | 66.26 Thousand USD | -361536.786% |
| Belite Bio, Inc | -399 Thousand USD | 60158.897% |
| XOMA Corporation | 3.86 Million USD | -6106.553% |
| ARS Pharmaceuticals, Inc. | -20.03 Million USD | 1296.022% |
| Bionomics Limited | -434.44 Thousand USD | 55258.373% |
| Apogee Therapeutics, Inc. | - USD | -Infinity% |
| Alpha Tau Medical Ltd. | -1.07 Million USD | 22412.384% |
| uniQure N.V. | 2.21 Million USD | -10718.736% |
| Cassava Sciences, Inc. | -89.42 Million USD | 367.979% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Poseida Therapeutics, Inc. | -92.06 Million USD | 360.278% |
| Forte Biosciences, Inc. | -9000.00 USD | 2662711.111% |
| Anebulo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Enlivex Therapeutics Ltd. | -835 Thousand USD | 28798.802% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| SeaStar Medical Holding Corporation | - USD | -Infinity% |
| FibroBiologics, Inc. Common Stock | -437 Thousand USD | 54936.384% |
| Altimmune, Inc. | -65.37 Million USD | 466.566% |
| Amicus Therapeutics, Inc. | 362.03 Million USD | 33.808% |
| Alpha Tau Medical Ltd. | -1.07 Million USD | 22412.384% |
| Compugen Ltd. | 31.45 Million USD | -661.834% |
| Peak Bio, Inc. | 367.76 Thousand USD | -65059.108% |
| Zevra Therapeutics, Inc. | 24.51 Million USD | -877.464% |
| Benitec Biopharma Inc. | 108 Thousand USD | -221784.259% |
| Spyre Therapeutics, Inc. | -78 Thousand USD | 307324.359% |
| NKGen Biotech, Inc. Common Stock | -1.2 Million USD | 20019.784% |
| Zura Bio Limited | - USD | -Infinity% |
| PolyPid Ltd. | -1.82 Million USD | 13252.305% |
| Aileron Therapeutics, Inc. | -119 Thousand USD | 201473.95% |
| NKGen Biotech, Inc. Warrants | -1.2 Million USD | 20019.784% |
| Instil Bio, Inc. | -4.75 Million USD | 5138.583% |
| argenx SE | 1.1 Billion USD | 78.382% |
| Immunome, Inc. | -8.9 Million USD | 2790.412% |
| Compass Therapeutics, Inc. | -1.89 Million USD | 12779.101% |
| Verona Pharma plc | -679.62 Thousand USD | 35359.938% |
| enGene Holdings Inc. Warrants | -175 Thousand USD | 137034.286% |
| Shattuck Labs, Inc. | -2.38 Million USD | 10147.589% |
| CervoMed Inc. | -1.29 Million USD | 18624.273% |
| LENZ Therapeutics, Inc. | -2.4 Million USD | 10055.754% |
| Plus Therapeutics, Inc. | -4.77 Million USD | 5116.433% |
| Dianthus Therapeutics, Inc. | 2.47 Million USD | -9597.896% |
| Moolec Science SA | -143.3 Thousand USD | 167320.264% |
| Enveric Biosciences, Inc. | -408.03 Thousand USD | 58829.75% |
| Inovio Pharmaceuticals, Inc. | -2.67 Million USD | 9069.96% |
| AnaptysBio, Inc. | 14.78 Million USD | -1521.237% |
| Design Therapeutics, Inc. | -537 Thousand USD | 44724.767% |
| Leap Therapeutics, Inc. | -427 Thousand USD | 56220.609% |
| NeurAxis, Inc. | 2.15 Million USD | -11011.168% |
| Seelos Therapeutics, Inc. | 2.14 Million USD | -11066.589% |
| Lumos Pharma, Inc. | 2 Million USD | -11839.96% |
| Achilles Therapeutics plc | -4.73 Million USD | 5164.922% |
| enGene Holdings Inc. Common Stock | -175 Thousand USD | 137034.286% |
| 180 Life Sciences Corp. | -105.67 Thousand USD | 226866.028% |
| Opiant Pharmaceuticals, Inc. | 31.65 Million USD | -656.931% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Nutriband Inc. | 862.1 Thousand USD | -27696.498% |
| ORIC Pharmaceuticals, Inc. | -1.03 Million USD | 23320.446% |
| CG Oncology, Inc. Common stock | -45.54 Million USD | 626.115% |
| Fractyl Health, Inc. Common Stock | 43 Thousand USD | -557190.698% |
| Rani Therapeutics Holdings, Inc. | -822 Thousand USD | 29252.676% |
| MoonLake Immunotherapeutics | -13.15 Thousand USD | 1821311.43% |
| Palisade Bio, Inc. | 246 Thousand USD | -97312.602% |
| Tourmaline Bio, Inc. | -33 Thousand USD | 726266.667% |
| Beam Therapeutics Inc. | -59.67 Million USD | 501.587% |
| Neurogene Inc. | -3.26 Million USD | 7446.26% |
| Mirum Pharmaceuticals, Inc. | 139.33 Million USD | -71.985% |
| AEON Biopharma, Inc. | - USD | -Infinity% |
| CARGO Therapeutics, Inc. Common Stock | -3.69 Million USD | 6590.655% |
| Sesen Bio, Inc. | 40 Million USD | -499.088% |
| Enliven Therapeutics, Inc. | -297 Thousand USD | 80785.185% |
| Kiora Pharmaceuticals, Inc. | -4.02 Million USD | 6050.653% |
| Iovance Biotherapeutics, Inc. | -9.56 Million USD | 2605.07% |
| Taysha Gene Therapies, Inc. | 14.08 Million USD | -1601.953% |
| Athira Pharma, Inc. | -969 Thousand USD | 24830.134% |
| Vaccinex, Inc. | -16 Million USD | 1597.344% |
| HCW Biologics Inc. | -574.82 Thousand USD | 41788.412% |
| XOMA Corporation | 3.86 Million USD | -6106.553% |
| Nektar Therapeutics | 53.47 Million USD | -348.1% |
| Arvinas, Inc. | 71.8 Million USD | -233.753% |
| Tevogen Bio Holdings Inc. | - USD | -Infinity% |
| Merus N.V. | -83.46 Million USD | 387.122% |
| Omega Therapeutics, Inc. | -62.77 Million USD | 481.736% |
| Quince Therapeutics, Inc. | -322 Thousand USD | 74520.807% |
| Rezolute, Inc. | -36 Thousand USD | 665752.778% |
| Clene Inc. | 533 Thousand USD | -44859.662% |
| Indaptus Therapeutics, Inc. | -1284.00 USD | 18663261.994% |
| BeyondSpring Inc. | 1.75 Million USD | -13585.608% |
| Synlogic, Inc. | -1.92 Million USD | 12555.042% |
| Allarity Therapeutics, Inc. | -37 Thousand USD | 647762.162% |
| Phio Pharmaceuticals Corp. | -6.33 Million USD | 3884.507% |
| Peak Bio, Inc. | 367.76 Thousand USD | -65059.108% |
| Werewolf Therapeutics, Inc. | -18.96 Million USD | 1363.698% |
| Krystal Biotech, Inc. | 47.6 Million USD | -403.382% |
| Karyopharm Therapeutics Inc. | 141.09 Million USD | -69.844% |
| SpringWorks Therapeutics, Inc. | 5.02 Million USD | -4668.856% |
| Lipella Pharmaceuticals Inc. | -2.58 Million USD | 9355.107% |
| MannKind Corporation | 136.19 Million USD | -75.955% |
| Ikena Oncology, Inc. | -50.49 Million USD | 574.6% |
| Cyclerion Therapeutics, Inc. | - USD | -Infinity% |
| Gyre Therapeutics, Inc. | 108.81 Million USD | -120.224% |
| Gossamer Bio, Inc. | -4.38 Million USD | 5564.88% |
| CohBar, Inc. | - USD | -Infinity% |
| Cognition Therapeutics, Inc. | -252 Thousand USD | 95193.254% |
| NRx Pharmaceuticals, Inc. | -5000.00 USD | 4792800.0% |
| Legend Biotech Corporation | 140.92 Million USD | -70.04% |
| Mural Oncology plc | -2.56 Million USD | 9435.216% |
| Biora Therapeutics, Inc. | -551 Thousand USD | 43590.926% |
| PaxMedica, Inc. Common Stock | - USD | -Infinity% |
| Disc Medicine, Inc. | -100 Thousand USD | 239735.0% |
| Champions Oncology, Inc. | 20.75 Million USD | -1054.645% |
| REGENXBIO Inc. | 53.02 Million USD | -351.894% |
| Ensysce Biosciences, Inc. | -5.35 Million USD | 4573.345% |
| Anavex Life Sciences Corp. | - USD | -Infinity% |
| Cellectar Biosciences, Inc. | -192.37 Thousand USD | 124666.602% |
| Edgewise Therapeutics, Inc. | -1.73 Million USD | 13935.739% |
| Vaxart, Inc. | -60.76 Million USD | 494.377% |
| PharmaCyte Biotech, Inc. | - USD | -Infinity% |
| Aldeyra Therapeutics, Inc. | -262.78 Thousand USD | 91292.252% |
| Cellectis S.A. | 18 Thousand USD | -1331205.556% |
| Longeveron Inc. | 221 Thousand USD | -108332.127% |
| Repare Therapeutics Inc. | -80.07 Million USD | 399.282% |
| Sarepta Therapeutics, Inc. | 1.09 Billion USD | 78.075% |
| Inozyme Pharma, Inc. | -1.29 Million USD | 18618.934% |
| Revolution Medicines, Inc. | -399.66 Million USD | 159.959% |
| Nymox Pharmaceutical Corporation | - USD | -Infinity% |
| Third Harmonic Bio, Inc. | -35 Thousand USD | 684771.429% |
| ArriVent BioPharma, Inc. Common Stock | - USD | -Infinity% |
| AN2 Therapeutics, Inc. | - USD | -Infinity% |
| Anixa Biosciences, Inc. | 49 Thousand USD | -488951.02% |
| Vertex Pharmaceuticals Incorporated | 8.6 Billion USD | 97.216% |
| Denali Therapeutics Inc. | -93.34 Million USD | 356.72% |
| Revelation Biosciences, Inc. | -25.04 Thousand USD | 956764.937% |
| Veru Inc. | 7.56 Million USD | -3067.292% |
| Corvus Pharmaceuticals, Inc. | -151 Thousand USD | 158798.675% |
| Cingulate Inc. | -582.91 Thousand USD | 41209.556% |
| Passage Bio, Inc. | -3.72 Million USD | 6540.07% |
| Context Therapeutics Inc. | -12.04 Thousand USD | 1989762.903% |
| Exicure, Inc. | -1.42 Million USD | 16940.126% |
| Day One Biopharmaceuticals, Inc. | -383 Thousand USD | 62667.885% |
| Oramed Pharmaceuticals Inc. | 2.7 Million USD | -8765.52% |
| Scinai Immunotherapeutics Ltd. | -512.67 Thousand USD | 46842.088% |
| Rhythm Pharmaceuticals, Inc. | 68.12 Million USD | -251.753% |
| Nuvalent, Inc. | - USD | -Infinity% |
| ABVC BioPharma, Inc. | -149.6 Thousand USD | 160276.329% |
| Carisma Therapeutics, Inc. | -59.2 Million USD | 504.748% |
| Unicycive Therapeutics, Inc. | 391 Thousand USD | -61187.724% |
| OmniAb, Inc. | 14.66 Million USD | -1533.838% |
| Anew Medical, Inc. | - USD | -Infinity% |
| Fennec Pharmaceuticals Inc. | 19.99 Million USD | -1098.595% |
| Lipocine Inc. | -2.85 Million USD | 8505.833% |
| Lexeo Therapeutics, Inc. Common Stock | -1.84 Million USD | 13102.442% |
| Nautilus Biotechnology, Inc. | -5.7 Million USD | 4300.438% |
| SAB Biotherapeutics, Inc. | -1.5 Million USD | 16008.945% |
| G1 Therapeutics, Inc. | 75.31 Million USD | -218.173% |
| Bellerophon Therapeutics, Inc. | -65 Thousand USD | 368769.231% |
| Sage Therapeutics, Inc. | 84.29 Million USD | -184.278% |
| Ocugen, Inc. | -33.53 Million USD | 814.539% |
| Mind Medicine (MindMed) Inc. | -3.16 Million USD | 7678.59% |
| Q32 Bio Inc. | 578 Thousand USD | -41359.343% |
| Brainstorm Cell Therapeutics Inc. | -265 Thousand USD | 90528.302% |
| Alumis Inc. Common Stock | -1.28 Million USD | 18763.162% |
| Equillium, Inc. | 35.95 Million USD | -566.43% |
| Kyverna Therapeutics, Inc. | -1.7 Million USD | 14138.371% |
| Coya Therapeutics, Inc. | 500.67 Thousand USD | -47762.003% |
| CNS Pharmaceuticals, Inc. | -4134.00 USD | 5796786.018% |
| Galera Therapeutics, Inc. | -259 Thousand USD | 92623.166% |
| Evelo Biosciences, Inc. | - USD | -Infinity% |
| Comera Life Sciences Holdings, Inc. | 422.71 Thousand USD | -56589.898% |
| Dominari Holdings Inc. | 2.03 Million USD | -11652.575% |
| Edesa Biotech, Inc. | -183.47 Thousand USD | 130711.922% |
| vTv Therapeutics Inc. | -13.59 Million USD | 1862.67% |
| Bio-Techne Corporation | 773.07 Million USD | 69.002% |
| Agios Pharmaceuticals, Inc. | 17.31 Million USD | -1283.654% |
| Harmony Biosciences Holdings, Inc. | 460.78 Million USD | 47.994% |
| Prelude Therapeutics Incorporated | -1.16 Million USD | 20599.145% |
| Candel Therapeutics, Inc. | -23.98 Million USD | 1099.312% |
| iTeos Therapeutics, Inc. | 11.69 Million USD | -1948.688% |
| Nkarta, Inc. | -5.86 Million USD | 4183.064% |
| BioCardia, Inc. | -7.24 Million USD | 3405.766% |
| Iterum Therapeutics plc | -1.75 Million USD | 13793.429% |